세계의 연구 및 제조 위탁 서비스(CRAMS) 시장

Global Contract Research and Manufacturing Services (CRAMS) Market to Reach US$211.4 Billion by 2030

The global market for Contract Research and Manufacturing Services (CRAMS) estimated at US$128.8 Billion in the year 2023, is expected to reach US$211.4 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2023-2030. Manufacturing Service, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$126.8 Billion by the end of the analysis period. Growth in the Research Service segment is estimated at 8.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$35.1 Billion While China is Forecast to Grow at 11.5% CAGR

The Contract Research and Manufacturing Services (CRAMS) market in the U.S. is estimated at US$35.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$46.5 Billion by the year 2030 trailing a CAGR of 11.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 7.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Contract Research and Manufacturing Services (CRAMS) Market - Key Trends and Drivers Summarized

Contract Research and Manufacturing Services (CRAMS) encompass a broad spectrum of outsourcing services provided by companies to the pharmaceutical and biotechnological sectors. CRAMS allow drug developers to delegate specific R&D processes and manufacturing tasks to external partners. These services cover a wide range of activities, from early-stage drug discovery, preclinical trials, and clinical research to large-scale commercial manufacturing and API (active pharmaceutical ingredient) production. By leveraging CRAMS, pharmaceutical companies can significantly reduce capital investment and operational costs, streamline product development timelines, and enhance flexibility in managing the fluctuating demands of drug development and production. Moreover, CRAMS providers offer specialized expertise and advanced facilities that many pharmaceutical companies might not possess internally, making them an integral component of today’s drug development landscape.

The CRAMS industry has adapted to meet the evolving needs of the global healthcare sector, focusing on flexibility, scalability, and state-of-the-art technological integration. As biopharmaceutical products become more complex, the demand for sophisticated and specialized manufacturing techniques has escalated. CRAMS providers have responded by investing in cutting-edge technologies such as continuous manufacturing and bioreactors, which are crucial for the production of biologics and advanced therapy medicinal products (ATMPs), including gene and cell therapies. This trend is supported by a move towards more personalized medicine approaches, which require the production of small batches of highly specialized drugs. Furthermore, CRAMS providers have developed strong regulatory expertise to navigate the complex and varying global regulatory landscapes, ensuring compliance and facilitating smoother market entries for new drugs.

The growth in the CRAMS market is driven by several factors, including the increasing complexity of pharmaceutical production, heightened cost pressures faced by drug developers, and a surge in the number of small to mid-size biotech companies. Technological advancements in drug development processes have necessitated the adoption of highly specialized manufacturing capabilities that many pharmaceutical companies do not have in-house. This has increased their reliance on CRAMS providers who possess the necessary technological infrastructure and expertise. Additionally, the rising focus on cost-efficiency within the pharmaceutical industry has propelled companies to seek external partners that can provide economies of scale and scope in both research and production phases. Consumer behavior has also influenced the CRAMS market, particularly as there is an increasing demand for faster development and delivery of new therapies to the market, which CRAMS can facilitate. Moreover, the growth of the biologics sector, which requires distinct production environments and expertise, continues to drive the expansion of CRAMS, making it an essential component of the modern pharmaceutical supply chain.

Select Competitors (Total 86 Featured) -

• AbbVie Inc.
• Arch Pharmalabs Ltd.
• Calyx Chemicals and Pharmaceuticals Ltd.
• Globela Pharma Pvt. Ltd.
• Ind-Swift Laboratories Ltd.
• Merck KGaA,
• MSN Laboratories
• Murli Krishna Pharma Private Ltd.
• Novartis AG
• Orchid Pharma Ltd.
• SMS Pharmaceuticals Ltd.
• Sun Pharmaceutical Industries Ltd.
• Thermo Fisher Scientific Inc.
• Ultratech India Limited
• VIVAN Life Sciences Pvt Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Contract Research and Manufacturing Services (CRAMS) - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increased Outsourcing by Pharmaceutical Companies Boosts CRAMS Market
  • Growing Demand for Biologics and Biosimilars Stimulating CRAMS Growth
  • Rise of Generic Pharmaceuticals Amplifying CRAMS Opportunities
  • Regulatory Changes and Compliance Requirements Shaping CRAMS Dynamics
  • Advances in Manufacturing Technologies and Their Impact on CRAMS
  • Expansion of CRAMS in Emerging Markets
  • Strategic Alliances and Mergers Driving Market Consolidation
  • Impact of Global Health Crises on CRAMS Demand
  • Evolving Intellectual Property Laws and Their Influence on CRAMS
  • Sustainability Trends and Their Adoption in CRAMS Facilities
  • Digitalization and Automation Enhancing CRAMS Efficiency
  • Patient-centric Drug Development and Its Effects on CRAMS
  • Shift Towards Specialized Therapeutic Areas and Its Impact on CRAMS
  • Venture Capital Funding and Its Influence on CRAMS Expansion
  • Technological Innovations in Drug Development and Manufacturing
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Contract Research and Manufacturing Services (CRAMS) Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Contract Research and Manufacturing Services (CRAMS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Manufacturing Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Manufacturing Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for Manufacturing Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Research Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Research Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for Research Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Medical Device Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Medical Device Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Medical Device Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Academic Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Academic Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Academic Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Contract Research and Manufacturing Services (CRAMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 20: USA Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 21: USA Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 22: USA 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 23: USA Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 24: USA Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: USA 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 26: Canada Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 27: Canada Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: Canada 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 29: Canada Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: Canada Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: Canada 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• JAPAN
  • Contract Research and Manufacturing Services (CRAMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 32: Japan Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Japan Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: Japan 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 35: Japan Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Japan Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: Japan 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• CHINA
  • Contract Research and Manufacturing Services (CRAMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 38: China Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: China Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: China 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 41: China Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 42: China Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: China 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• EUROPE
  • Contract Research and Manufacturing Services (CRAMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 44: Europe Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 45: Europe Historic Review for Contract Research and Manufacturing Services (CRAMS) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: Europe 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 47: Europe Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Europe Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: Europe 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: Europe 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• FRANCE
  • Contract Research and Manufacturing Services (CRAMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 53: France Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: France Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: France 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 56: France Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: France Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: France 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• GERMANY
  • Contract Research and Manufacturing Services (CRAMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 59: Germany Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Germany Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 61: Germany 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 62: Germany Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Germany Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 64: Germany 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 65: Italy Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 66: Italy Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 67: Italy 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 68: Italy Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Italy Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 70: Italy 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Contract Research and Manufacturing Services (CRAMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 71: UK Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 72: UK Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 73: UK 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 74: UK Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 75: UK Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 76: UK 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• SPAIN
  • TABLE 77: Spain Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 78: Spain Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 79: Spain 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 80: Spain Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 81: Spain Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 82: Spain 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• RUSSIA
  • TABLE 83: Russia Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 84: Russia Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 85: Russia 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 86: Russia Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Russia Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 88: Russia 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Rest of Europe Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 91: Rest of Europe 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Rest of Europe Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 94: Rest of Europe 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Contract Research and Manufacturing Services (CRAMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 96: Asia-Pacific Historic Review for Contract Research and Manufacturing Services (CRAMS) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 97: Asia-Pacific 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Asia-Pacific Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 100: Asia-Pacific 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Asia-Pacific Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 103: Asia-Pacific 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• AUSTRALIA
  • Contract Research and Manufacturing Services (CRAMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
  • TABLE 104: Australia Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 105: Australia Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 106: Australia 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 107: Australia Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 108: Australia Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 109: Australia 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• INDIA
  • Contract Research and Manufacturing Services (CRAMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • TABLE 110: India Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 111: India Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 112: India 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 113: India Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 114: India Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 115: India 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• SOUTH KOREA
  • TABLE 116: South Korea Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 117: South Korea Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 118: South Korea 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 119: South Korea Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 120: South Korea Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 121: South Korea 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 123: Rest of Asia-Pacific Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 126: Rest of Asia-Pacific Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• LATIN AMERICA
  • Contract Research and Manufacturing Services (CRAMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
  • TABLE 128: Latin America Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 129: Latin America Historic Review for Contract Research and Manufacturing Services (CRAMS) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 130: Latin America 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • TABLE 131: Latin America Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 132: Latin America Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 133: Latin America 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 134: Latin America Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 135: Latin America Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 136: Latin America 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• ARGENTINA
  • TABLE 137: Argentina Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 138: Argentina Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 139: Argentina 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 140: Argentina Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 141: Argentina Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 142: Argentina 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• BRAZIL
  • TABLE 143: Brazil Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 144: Brazil Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 145: Brazil 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 146: Brazil Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 147: Brazil Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 148: Brazil 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• MEXICO
  • TABLE 149: Mexico Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 150: Mexico Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 151: Mexico 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 152: Mexico Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 153: Mexico Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 154: Mexico 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• REST OF LATIN AMERICA
  • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 156: Rest of Latin America Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 157: Rest of Latin America 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 159: Rest of Latin America Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 160: Rest of Latin America 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• MIDDLE EAST
  • Contract Research and Manufacturing Services (CRAMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
  • TABLE 161: Middle East Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 162: Middle East Historic Review for Contract Research and Manufacturing Services (CRAMS) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 163: Middle East 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • TABLE 164: Middle East Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 165: Middle East Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 166: Middle East 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 167: Middle East Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 168: Middle East Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 169: Middle East 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• IRAN
  • TABLE 170: Iran Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 171: Iran Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 172: Iran 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 173: Iran Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 174: Iran Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 175: Iran 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• ISRAEL
  • TABLE 176: Israel Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 177: Israel Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 178: Israel 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 179: Israel Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 180: Israel Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 181: Israel 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• SAUDI ARABIA
  • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 183: Saudi Arabia Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 184: Saudi Arabia 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 186: Saudi Arabia Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 187: Saudi Arabia 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• UNITED ARAB EMIRATES
  • TABLE 188: UAE Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 189: UAE Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 190: UAE 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 191: UAE Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 192: UAE Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 193: UAE 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• REST OF MIDDLE EAST
  • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 195: Rest of Middle East Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 196: Rest of Middle East 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 198: Rest of Middle East Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 199: Rest of Middle East 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030
• AFRICA
  • Contract Research and Manufacturing Services (CRAMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
  • TABLE 200: Africa Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 201: Africa Historic Review for Contract Research and Manufacturing Services (CRAMS) by Service Type - Manufacturing Service and Research Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 202: Africa 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by Service Type - Percentage Breakdown of Value Sales for Manufacturing Service and Research Service for the Years 2014, 2024 & 2030
  • TABLE 203: Africa Recent Past, Current & Future Analysis for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 204: Africa Historic Review for Contract Research and Manufacturing Services (CRAMS) by End-Use - Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 205: Africa 16-Year Perspective for Contract Research and Manufacturing Services (CRAMS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Medical Device Companies End-Use and Academic Institutes End-Use for the Years 2014, 2024 & 2030

IV. COMPETITION